# DESCRIPTION

## FIELD

- define field of disclosure

## INTRODUCTION

- motivate need for alternative methods

## SUMMARY

- describe guide RNA molecule
- describe DNA targeting system

## DETAILED DESCRIPTION

- introduce CRISPR/Cas systems
- application to myogenic progenitor cell differentiation

### 1. Definitions

- define technical terms
- explain transitional phrases
- describe numeric ranges
- define specific terms (e.g. "about", "adeno-associated virus", "amino acid")
- define genetic and molecular biology terms (e.g. "binding region", "clustered regularly interspaced short palindromic repeats", "coding sequence
- define key terms
- describe protein structures and functions
- explain gene expression and regulation
- detail CRISPR/Cas9-based gene editing system
- describe TALE and zinc finger proteins
- define sample and subject
- explain treatment and variant

### 2. Pax7

- define Pax7

### 3. CRISPR/Cas-Based Gene Editing System

- introduce CRISPR/Cas-based gene editing system
- describe CRISPR system and its components
- explain Type II effector system and its mechanism
- discuss Cas9 protein and its functions
- describe engineered CRISPR/Cas9-based systems for genome editing
- introduce Cas protein and its variants
- explain PAM sequence recognition and cleavage
- describe fusion proteins with Cas protein and their activities
- discuss applications of CRISPR/Cas-based gene editing system
- describe CRISPR/Cas-based gene editing system
- list activities of second polypeptide domain
- define gRNA molecule
- describe gRNA targeting portion and scaffold
- outline gRNA molecule composition and function
- describe DNA targeting system composition

### 4. Genetic Constructs

- describe genetic constructs for DNA targeting system

### 5. Pharmaceutical Compositions

- formulate genetic constructs into pharmaceutical compositions

### 6. Administration

- administer DNA targeting systems or pharmaceutical compositions to subjects
- describe routes of administration

### 7. Methods

- describe methods for activating Pax7, differentiating stem cells, and treating subjects

### 8. Examples

- describe materials and methods for Example 1
- outline cell culture and differentiation procedures
- detail flow cytometry analysis and cell sorting
- describe cell transplantation into immunodeficient mice
- outline immunofluorescence staining and imaging
- describe quantitative reverse transcription PCR and chromatin immunoprecipitation
- outline RNA sequencing and data analysis
- present experimental results
- demonstrate in vivo regenerative potential
- show sustained PAX7 expression
- analyze chromatin remodeling
- identify global transcriptional changes
- compare endogenous vs. exogenous PAX7-induced changes

### Discussion

- introduce CRISPR/Cas9-based transcriptional activators
- motivate PAX7 gene activation for myogenic progenitor cell differentiation
- describe advantages of endogenous PAX7 activation over PAX7 cDNA overexpression
- discuss potential of VP64-dCas9-VP64 for integration-free reprogramming
- summarize implications for disease modeling and cell therapy

